Editor Conflict of Interest Disclosures


A PDF of the Editors' conflict of interest disclosure information is available for download here.

Member, Board of Directors: Varian Biopharma

Consulting: Samus Therapeutics, Partner Therapeutics, Ascentage, Oncology Analytics

Honoraria: Pfizer, Genentech/Roche

Speakers' Bureau: Pfizer

Honoraria: Pfizer

Consulting or Advisory Role: UnitedHealthcare

Research Funding: Novartis

No conflicts to report

Honoraria: Prime Oncology, Elsevier, Itamar Medical

Consulting or Advisory Role: Monteris Medical, Incyte, AstraZeneca, Bristol-Myers Squibb, Abbvie

Research Funding: Novartis, TRACON Pharma, Novocure, Spectrum Pharmaceuticals, Lilly/ImClone, Boehringer Ingelheim

Honoraria: AstraZeneca, Eisai, Genentech/Roche, Ipsen, Puma, and Seattle Genetics

Consulting/Advisory: AstraZeneca, Eisai, Genentech/Roche, Ipsen, Puma Biotechnology, and Seattle Genetics

Institutional Research Funding: G1-Therapeutics, Lilly, Merck, Nektar, Puma Biotechnology, Seattle Genetics, and Tesaro

Intellectual Property: Jones and Bartlett and

Travel, Accommodations, or other Expenses: Eisai

No conflicts to report

Consulting or Advisory Role: INC Research and Cyt RX, Marathon Pharma, Morphotek

No conflicts to report

No conflicts to report

No conflicts to report

No conflicts to report

Employment: Flatiron Health

Patents, Royalties, & Other Intellectual Property: Patents pending relating to inventions as employee of NCCN

Other Relationships: National Comprehensive Cancer Network

Employment: Texas Oncology, University of Texas Southwestern Medical Center - Simmons Cancer

Leadership: Texas Oncology, Parkland Health System

Stock & Other Ownership Interests: Amgen, Medfusion, Merck, Pfizer

Research Funding: US Oncology

Other Relationships: Mary Crowley Research Center (Dallas, Texas), American Society of Clinical Oncology, Methodist Health System (Dallas, Texas)

No conflicts to report

Leadership: Blueprint Medicines

Stock & Other Ownership Interests: Blueprint Medicines, G1 Therapeutics, Bessor Pharma, Caris Life Sciences, Champions Oncology, N-of-One

Consulting or Advisory Role: Bayer, Pfizer, Novartis, Lilly, EMD Serono, Sanofi, Janssen Oncology, PharmaMar, Daiichi Sankyo, Blueprint Medicines, Kolltan Pharmaceuticals, WIRB-Copernicus Group, ZIOPHARM Oncology, Polaris, Nektar, Genocea Biosciences, G1 Therapeutics, Caris Life Sciences, Adaptimmune, Eisai, Kyocera

Research Funding: Abbvie, Janssen Oncology

Patents, Royalties, & Other Intellectual Property: Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber and Novartis

Consulting/Advisory: Array BioPharma, Bayer Schering Pharma, Foundation of Medicine, and Natera

Consulting or Advisory Role: AMAG Pharmaceuticals, ARIAD, Biodesix, Boehringer Ingelheim, Eisai, Gilead Sciences, Helsinn Therapeutics, Lilly, Roche/Genentech

Research Funding: Puma Biotechnology

No conflicts to report

No conflicts to report

No conflicts to report

Consulting/Advisory: Adaptive Biotechnologies, CStone Pharmaceuticals, Dragonfly Therapeutics, Genocea Biosciences, and Incyte

Research Funding: Aduro Biotech, Amgen, Bristol-Myers Squibb, and Corvus Pharmaceuticals;

Intellectual Property: GVAX (and has received yearly milestone payments for it)

Travel, Accommodations, or Other Expenses: Bristol-Myers Squibb, Genocea Biosciences, and MedImmune

Other Relationships: Dragonfly Therapeutics

Honoraria: CMP Healthcare Oncology Publishing, The ASCO Post

Consulting or Advisory Role: CommGeniX, International Genetics, AlphaSights

Travel, Accommodations, Expenses: Hospital Association of PA, Bristol-Myers Squibb

Other Relationships: BP

Research Funding: Pfizer, Amgen, Bristol-Myers Squibb, Novartis

Leadership: Cellworks, LifeLink

Consulting or Advisory Role: Integra

Consulting or Advisory Role: Magellan Health

Consulting/Advisory Board: AstraZeneca

Advisory Board: Novocure, Guardant Health, Takeda

Honoraria: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Consulting or Advisory Role: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Speakers' Bureau: Genentech/Roche, Amgen, Bayer/Onyx

Research Funding: Bayer/Onyx, Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, MedImmune

Honoraria: Advaxis

Consulting or Advisory Role: Merck, NextCure, and Novartis

Research Funding: Fujifilm, Immunogen, Leap Therapeutics, Merck, Mersana, Novartis, SQZ Biotechnologies, Syndax, and Tesaro

Travel, Accommodations, Other Expenses: AstraZeneca

No conflicts to report

Consulting or Advisory Role: Boehringer Ingelheim

Research Funding: Boehringer Ingelheim, AstraZeneca, Exelixis, Novartis, MedImmune, Merck, Genentech/Roche, Lilly, Bayer

Consulting or Advisory Role: Gerson Lehrman Group, Caris Life Sciences

Stock & Other Ownership Interests: AuraSense LLC, Nanosphere Inc.

Honoraria: Celgene, Pharmacyclics, Janssen Biotech, Valeant Pharmaceuticals International

Consulting or Advisory Role: Celgene, Genetech Health Practices Consulting, Seattle Genetics

Research Funding: Celgene, Lilly

Research Funding: Eisai, Pfizer

Institutional Research Funding: AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Genentech/Roche, Lilly, Merck, and Pfizer

Honoraria: Pfizer, Amgen, Bristol-Myers Squibb, Tesaro

Consulting or Advisory Role: Amgen, Bristol-Myers Squibb, Pfizer, Helsinn Therapeutics

Speakers' Bureau: Genentech/Roche

Research Funding: Helsinn Therapeutics

Honoraria: Genomic Health, Eisai, Genentech/Roche, Celgene

Consulting or Advisory Role: Genentech/Roche, Pfizer, Celgene, Eisai

Speakers' Bureau: Genomic Health, Eisai, Genentech/Roche, Celgene

Research Funding: Bayer

Travel, Accommodations, Expenses: Genomic Health, Genentech/Roche, Eisai, Celgene

Consulting or Advisory Role: 3M, BlueCross and BlueShield of Michigan, Amgen

Employment: UpToDate

Patents, Royalties, & Other Intellectual Property: UpToDate, Royalties from Oxford Textbook of Cancer Communication, co-editor

Travel, Accommodations, Expenses: GEOMC, Inc. Seoul, Korea

No conflicts to report as of 7/13/18

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Genomic Health

Travel, Accommodations, Expenses: TEVA, Tel Aviv

Research Funding: Astellas Pharma, Chimerix, and Merck

Honoraria: Bayer, Bristol-Myers Squibb, Fresenius Kabi, Roche, Pfizer

Consulting or Advisory Role: Bayer, Pfizer

Speakers' Bureau: Bayer, Daiichi Sankyo

Travel, Accommodations, Expenses: Pfizer

No conflicts to report

Leadership: IBA - Ion Beam Applications

Consulting or Advisory Role: IBA

Travel, Accommodations, Expenses: IBA

Consulting or Advisory Role: AstraZeneca, Amgen, Boehringer Ingelheim

Speakers' Bureau: Roche

Honoraria: Roche, Novartis, Pfizer, MSD Oncology, Lilly

Research Funding: Roche

Travel, Accommodations, Expenses: Celgene, MSD Oncology, Roche, Novartis

No conflicts to report

Consulting or Advisory Role: Bristol-Myers Squibb, AstraZeneca, MSD Oncology

Speakers' Bureau: MSD Oncology, Bristol-Myers Squibb

Travel, Accommodations, Expenses: Bristol-Myers Squibb, Pfizer